JB Chemicals & Pharmaceuticals Limited — Updates, 11-11-2025: Press Release
11-11-2025 | 05:11 pm
11-11-2025 | 05:11 pm
JB Pharma's Q2 FY26 revenue rose 8% to ₹1085 Cr, with EBITDA up 12% to ₹319 Cr and Net Profit jumping 19% to ₹208 Cr. Domestic business outperformed the market; International CDMO segment shows strong momentum with a robust order book.
No comments yet. Be the first to comment!
All announcements from JB Chemicals & Pharmaceuticals Limited
